Citadel Advisors’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.22M | Buy |
+1,319,266
| New | +$7.22M | ﹤0.01% | 1603 |
|
|
2025
Q1 | – | Sell |
-1,233,176
| Closed | -$5.08M | – | 6936 |
|
|
2024
Q4 | $5.08M | Buy |
1,233,176
+1,183,295
| +2,372% | +$4.88M | ﹤0.01% | 1789 |
|
|
2024
Q3 | $167K | Buy |
+49,881
| New | +$167K | ﹤0.01% | 4725 |
|
|
2024
Q2 | – | Sell |
-28,680
| Closed | -$98.9K | – | 6826 |
|
|
2024
Q1 | $98.9K | Sell |
28,680
-156,378
| -85% | -$540K | ﹤0.01% | 5085 |
|
|
2023
Q4 | $248K | Buy |
185,058
+157,977
| +583% | +$212K | ﹤0.01% | 4411 |
|
|
2023
Q3 | $59K | Sell |
27,081
-33,372
| -55% | -$72.8K | ﹤0.01% | 5019 |
|
|
2023
Q2 | $144K | Sell |
60,453
-11,202
| -16% | -$26.8K | ﹤0.01% | 4588 |
|
|
2023
Q1 | $133K | Buy |
71,655
+27,439
| +62% | +$50.8K | ﹤0.01% | 4807 |
|
|
2022
Q4 | $85.3K | Buy |
+44,216
| New | +$85.3K | ﹤0.01% | 5079 |
|
|
2022
Q1 | – | Sell |
-49,849
| Closed | -$39K | – | 7127 |
|
|
2021
Q4 | $39K | Buy |
49,849
+31,702
| +175% | +$24.8K | ﹤0.01% | 6219 |
|
|
2021
Q3 | $25K | Buy |
+18,147
| New | +$25K | ﹤0.01% | 6264 |
|
|
2021
Q2 | – | Sell |
-10,617
| Closed | -$29K | – | 7105 |
|
|
2021
Q1 | $29K | Buy |
+10,617
| New | +$29K | ﹤0.01% | 6167 |
|